Search Results - "Moreb, J.S."

Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw by Katz, J, Gong, Y, Salmasinia, D, Hou, W, Burkley, B, Ferreira, P, Casanova, O, Langaee, T.Y, Moreb, J.S

“…Abstract Bisphosphonate induced osteonecrosis of the jaw (BONJ) is a complication in patients taking bisphosphonate (BP) that affects their quality of life and…”
Get full text

Continuous Infusion Cyclophosphamide and Low-Dose Total Body Irradiation Is a Safe and Effective Conditioning Regimen for Autologous Transplant in Multiple Myeloma by Byrne, M, Wingard, J.R, Moreb, J.S

“…Abstract We present the results of a novel conditioning regimen in multiple myeloma (MM) patients undergoing tandem autologous stem cell transplant (ASCT). MM…”
Get full text

Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104 by Holstein, S.A, Owzar, K, Richardson, P.G, Jiang, C, Hofmeister, C.C, Hassoun, H, Hurd, D.D, Stadtmauer, E.A, Giralt, S, Devine, S.M, Hars, V, Postiglione, J, Weisdorf, D.J, Vij, R, Moreb, J.S, Callander, N.S, Pasquini, M.C, Martin, T.G, Shea, T.C, Anderson, K, McCarthy, P.L

Get full text

Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation by Gordan, L.N., Sugrue, M.W., Lynch, J.W., Williams, K.D., Khan, S.A., Wingard, J.R., Moreb, J.S.

“…The effect of poor blood stem cells mobilization on the outcome of autologous stem cell transplantation (ASCT) has not been well studied. Our aim is to…”
Get full text

Skeletal CT Scan Is More Sensitive Than Skeletal Survey During the Pre-Transplant Evaluation for Multiple Myeloma Patients But Has No Prognostic Significance by Moreb, J.S, Pettiford, L, Salejee, I, Bush, C

Get full text

Combination Of Ifn-α/GM-CSF as Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): Results of a Prospective Phase II Study by Salmasinia, D, Moreb, J.S

Get full text

Single Versus Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma Patients and Role of Second Salvage Transplant: A Single Center Prospective Phase II Study by Moreb, J.S, Salmasinia, D, Leather, H, Davis, A, Hsu, J.W, Wiggins, L, Cogle, C.R, Chang, M.N, Wingard, J.R

Get full text

Extramedullary disease in plasma cell myeloma: the iceberg phenomenon by Wirk, B, Wingard, J R, Moreb, J S

“…Extramedullary (EM) plasmacytomas (EMPs) that are not progression of intramedullary (IM) plasma cell myeloma (PCM) are usually indolent. In contrast, EM spread…”
Get full text

189: Non-Myeloablative Allogeneic Stem Cell Transplantation to Treat High Risk Heavily Pretreated Multiple by Moreb, J.S, Wirk, B.M, Cogle, C, Jamieson, K.J, Hsu, J, Wingard, J.R

Get full text

Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation by MACHADO, M, MOREB, J. S, KHAN, S. A

“…Alopecia, a side effect of chemotherapy, is usually temporary and reversible. Irreversible alopecia has been reported after high-dose chemotherapy (HDC) and…”
Get full text

Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma by Gordan, L N, Sugrue, M W, Lynch, J W, Williams, K D, Khan, S A, Moreb, J S

“…The importance of the association between early lymphocyte recovery and outcome has not been well studied in autologous stem cell transplantation (ASCT). In…”
Get full text

Reversal of severe graft-versus-host disease after non-myeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells by Khan, S.A., Moreb, J.S.

Get full text

Persistently low serum osteoprotegrin levels during the treatment of multiple myeloma patients predicts worse event-free survival by Moreb, J.S., Zucali, J.R., Roberts, C.

Get full text

Flow cytometric monitoring of normal plasma cells after autologous stem cell transplantation for multiple myeloma (MM) by Liu, H., Yuan, C.M., Braylan, R., Wingard, J.R., Moreb, J.S.

Get full text

GM-CSF and interferon-α maintenance therapy for multiple myeloma patients after autologous stem cell transplantation (ASCT): An interim report by Gowda, S., Cogle, C.R., Khan, S.A., Moreb, J.S.

Get full text

Tandem autografts for multiple myeloma patients using two different conditioning regimens: An interim analysis by Liu, H., Roberts, C., Pumphrey, P., Wingard, J.R., Moreb, J.S.

Get full text

Non-melphalan based conditioning regimens for tandem autografts in multiple myeloma patients by Moreb, J.S., Pumphrey, P., Khan, S.A., Leather, H., Finiewicz, K.J., Reddy, V.S., Wingard, J.R.

Get full text

196Non-Myeloablative Stem Cell Transplantation (SCT) is safe and effective for patients with multiple myeloma by Moreb, J.S., Cogle, C.R., Leather, H.L., Wiggins, L., Finiewicz, K.J., Khan, S.A., Reddy, V.S., Wingard, J.R.

Get full text

The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost by Sugrue, M W, Hutcheson, C E, Fisk, D D, Roberts, C G, Mageed, A, Wingard, J R, Moreb, J S

“…The cost of harvesting, processing, and freezing multiple peripheral blood stem cell (PBSC) products could easily exceed that of bone marrow harvest. To reduce…”
Get more information